https://doi.org/10.4081/itjm.2014.435
Treatment of moderate neuroleptic malignant syndrome
Submitted: 29 September 2013
Accepted: 17 December 2013
Published: 17 January 2014
Accepted: 17 December 2013
Abstract Views: 962
PDF: 780
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Authors
Downloads
Download data is not yet available.
PlumX Metrics
PlumX Metrics provide insights into the ways people interact with individual pieces of research output (articles, conference proceedings, book chapters, and many more) in the online environment. Examples include, when research is mentioned in the news or is tweeted about. Collectively known as PlumX Metrics, these metrics are divided into five categories to help make sense of the huge amounts of data involved and to enable analysis by comparing like with like.
Citations
How to Cite
Sanaei-Zadeh, H. (2014). Treatment of moderate neuroleptic malignant syndrome. Italian Journal of Medicine, 8(3), 199. https://doi.org/10.4081/itjm.2014.435
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.
Similar Articles
- Vitorino Modesto dos Santos, Reply to: Emphysematous pyelonephritis: a case report , Italian Journal of Medicine: Vol. 10 No. 1 (2016)
- Manuel Monti, Giovanni Maria Vincentelli, Francesco Borgognoni, Giuseppe Murdolo, Feliciano Menghini, A dangerous adverse event in the use of dabigatran , Italian Journal of Medicine: Vol. 10 No. 3 (2016)
- Marco Masina, Paola Gnerre, Paola Granata, Roberto Nardi, What to know before starting the process of publishing in a medical journal , Italian Journal of Medicine: Vol. 11 No. 3 (2017)
- Paola Gnerre, Giorgio Vescovo, Paola Granata, Cecilia Politi, Andrea Fontanella, Dario Manfellotto, Roberto Nardi, How to choose and become a reviewer for a scientific medical journal , Italian Journal of Medicine: Vol. 12 No. 2 (2018)
- Francesco Serafini, Elia Vettore, Fabio Presotto, Area of admission and short-term care: is it still possible after the COVID pandemic? , Italian Journal of Medicine: Vol. 18 No. 2 (2024)
- Filippo Manelli, Maria Sofia Cotelli, Giovanni Lodoli, Stefano Bonetti, Marinella Turla, Cerebral microbleeds after COVID-19 infection: an Italian case report , Italian Journal of Medicine: Vol. 15 No. 3 (2021)
- Francesco Serafini, Giuseppe Fantin, Roberto Brugiolo, Onofrio Lamanna, Anna Aprile, Fabio Presotto, Outlier admissions of medical patients: prognostic implications of outlying patients. The experience of the Hospital of Mestre , Italian Journal of Medicine: Vol. 9 No. 3 (2015)
- Mehdi Dadkhah, Giorgio Bianciardi, Unworthy peer review process and publishing method , Italian Journal of Medicine: Vol. 11 No. 1 (2017)
- Shahryar Sorooshian, Peer review art , Italian Journal of Medicine: Vol. 11 No. 4 (2017)
- Italo Portioli, Nominalism in Medicine: the case of personalized medicine or precision medicine , Italian Journal of Medicine: Vol. 11 No. 4 (2017)
You may also start an advanced similarity search for this article.